Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 100.97B | 100.97B | 101.36B | 97.40B | 81.60B | 63.57B |
Gross Profit | 14.37B | 14.37B | 14.11B | 13.81B | 12.15B | 9.77B |
EBITDA | 4.96B | 5.20B | 4.80B | 4.98B | 3.69B | 2.54B |
Net Income | 2.66B | 2.66B | 2.50B | 2.74B | 2.09B | 1.34B |
Balance Sheet | ||||||
Total Assets | 63.69B | 63.69B | 65.13B | 64.08B | 59.15B | 49.32B |
Cash, Cash Equivalents and Short-Term Investments | 8.97B | 8.97B | 8.23B | 6.49B | 6.05B | 8.79B |
Total Debt | 1.50B | 1.50B | 1.73B | 5.09B | 2.87B | 1.70B |
Total Liabilities | 22.84B | 22.84B | 26.05B | 28.47B | 25.98B | 19.39B |
Stockholders Equity | 40.82B | 40.82B | 39.06B | 35.59B | 33.16B | 29.93B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.72B | 5.97B | -916.00M | -1.25B | 2.77B |
Operating Cash Flow | 0.00 | 1.82B | 6.08B | -716.00M | -890.00M | 3.14B |
Investing Cash Flow | 0.00 | -95.00M | -84.00M | -191.00M | -3.81B | -981.00M |
Financing Cash Flow | 0.00 | -1.31B | -4.42B | 1.20B | 2.05B | -660.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | 27.07B | 7.02 | 11.98% | 2.70% | -2.86% | 47.66% | |
79 Outperform | 47.40B | 15.89 | 9.38% | 2.11% | -0.46% | -25.32% | |
78 Outperform | 44.21B | 12.35 | 12.37% | 1.86% | 32.53% | 182.70% | |
76 Outperform | 27.17B | 10.76 | 7.81% | 4.54% | 5.49% | 17.69% | |
76 Outperform | ¥33.08B | 13.73 | 2.99% | 2.04% | -11.59% | ||
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
Takebishi Corporation reported its consolidated financial results for the three months ended June 30, 2025, showing an increase in net sales by 8.9% year-on-year to ¥25,542 million. Despite the rise in sales and operating profit, the profit attributable to owners of the parent decreased by 23.7%, indicating potential challenges in cost management or other operational areas.
Takebishi Corporation has announced the issuance of 21,800 new shares as restricted stock to its directors and executive officers, aiming to align their interests with shareholders and enhance corporate value. This move is part of a broader compensation plan approved by shareholders, designed to incentivize leadership to maintain and grow the company’s credibility and performance.